Expert Review of Pharmacoeconomics & Outcomes Research

Scope & Guideline

Delivering Impactful Insights for Optimal Healthcare Solutions

Introduction

Delve into the academic richness of Expert Review of Pharmacoeconomics & Outcomes Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1473-7167
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV PHARM OUT / Expert Rev. Pharmacoecon. Outcomes Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Expert Review of Pharmacoeconomics & Outcomes Research focuses on the critical evaluation of pharmacoeconomic studies and their implications for healthcare outcomes. Its scope encompasses a wide range of topics related to health economics, cost-effectiveness analysis, and the impact of healthcare interventions on patient outcomes.
  1. Pharmacoeconomics:
    The journal publishes comprehensive analyses of the economic aspects of drug therapies, including cost-effectiveness and budget impact analyses, to inform healthcare decision-making.
  2. Health Technology Assessment (HTA):
    Research on the methodologies and applications of HTA in evaluating the value of new health technologies, drugs, and interventions to guide policy and reimbursement decisions.
  3. Patient-reported Outcomes:
    Studies focusing on measuring and valuing health-related quality of life and patient-reported outcomes, which are critical for assessing the impact of treatments from the patient's perspective.
  4. Comparative Effectiveness Research:
    Analysis comparing the effectiveness, safety, and cost of different therapeutic interventions to provide evidence for clinical guidelines and policy-making.
  5. Digital Health and Innovation:
    Exploration of the economic implications of digital health technologies and innovations, including their role in improving medication adherence and patient outcomes.
  6. Global Health Economics:
    Research addressing pharmacoeconomic evaluations in various global contexts, particularly in low- and middle-income countries, to understand the broader implications of healthcare interventions.
The journal has seen a rise in interest in several emerging themes that align with contemporary challenges in pharmacoeconomics and healthcare delivery.
  1. Integration of Machine Learning and AI:
    There is a growing trend towards utilizing machine learning and artificial intelligence in health economic evaluations, offering novel approaches to predict outcomes and enhance decision-making.
  2. Value-Based Healthcare Models:
    An increased focus on value-based healthcare, with research exploring how to align reimbursement models with patient outcomes and overall healthcare value.
  3. Real-World Evidence (RWE):
    The importance of real-world evidence is gaining traction, with studies emphasizing the need to assess the effectiveness and economic impact of interventions in everyday clinical settings.
  4. Patient Engagement in Research:
    Emerging themes include the engagement of patients in the development of health economic evaluations, emphasizing the importance of incorporating patient preferences and experiences.
  5. Sustainability and Environmental Considerations:
    A new focus on incorporating sustainability metrics into health economic evaluations, addressing the environmental impact of healthcare interventions.
  6. Cross-Disciplinary Approaches:
    An increase in interdisciplinary research that combines insights from economics, public health, and clinical practice to address complex healthcare challenges.

Declining or Waning

While the journal has maintained a robust focus on pharmacoeconomics and health outcomes, certain themes appear to be waning in prominence based on recent publications.
  1. Traditional Cost-Utility Analyses:
    There is a noticeable decline in studies solely relying on traditional cost-utility analyses without integrating broader health economic perspectives or real-world evidence.
  2. Focus on Localized Studies:
    The emphasis on localized pharmacoeconomic studies is decreasing, with a shift towards more globally relevant research that can inform international health policies.
  3. Single Disease Focus:
    Research concentrating on singular diseases is becoming less common, as the journal increasingly favors studies that incorporate multi-condition perspectives or address comorbidities.
  4. Outdated Methodologies:
    There is a decline in the publication of studies utilizing outdated economic evaluation methodologies, as the field evolves towards more sophisticated and innovative approaches.
  5. Static Policy Evaluations:
    Research that merely evaluates existing policies without proposing actionable insights or innovations is becoming less prevalent, reflecting a need for more dynamic and forward-thinking analyses.

Similar Journals

Health Policy OPEN

Empowering global health discourse with accessible research.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

Journal of Comparative Effectiveness Research

Driving improvement in health outcomes through research.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Gesundheitsoekonomie und Qualitaetsmanagement

Exploring the Intersection of Healthcare Economics and Quality
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

BMC HEALTH SERVICES RESEARCH

Illuminating pathways to better health systems.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

European Journal of Health Economics

Exploring the Intersection of Health and Economics
Publisher: SPRINGERISSN: 1618-7598Frequency: 4 issues/year

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

Pharmacoeconomics-Open

Empowering Healthcare Decisions Through Open Research
Publisher: SPRINGER INT PUBL AGISSN: 2509-4262Frequency: 4 issues/year

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

British Journal of Surgery

Innovating surgical techniques for tomorrow's challenges.
Publisher: OXFORD UNIV PRESSISSN: 0007-1323Frequency: 13 issues/year

The British Journal of Surgery, published by OXFORD UNIV PRESS, stands as a preeminent periodical in the field of surgery, as evidenced by its impressive impact factor and esteemed ranking of #7 out of 551 in the Scopus category of Medicine - Surgery, placing it in the 98th percentile. Since its inception in 1913, the journal has dedicated itself to disseminating cutting-edge research, innovative surgical techniques, and comprehensive meta-analyses, thereby shaping the future of surgical practice and education. With a robust commitment to academic rigor, it has consistently maintained a prestigious position in the Q1 category of surgery as of 2023, affirming its relevance in the modern medical landscape. The journal provides essential access to healthcare professionals, researchers, and students passionate about advancing surgical knowledge and improving patient outcomes. Operated from its headquarters in Oxford, United Kingdom, the British Journal of Surgery is pivotal for anyone looking to stay at the forefront of surgical advancements.

Journal of Managed Care & Specialty Pharmacy

Transforming Pharmaceutical Practices for Better Outcomes
Publisher: ACAD MANAGED CARE PHARMACYISSN: 2376-0540Frequency: 12 issues/year

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

Applied Health Economics and Health Policy

Unlocking the potential of health economics for global well-being.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Journal of Pharmaceutical Health Services Research

Advancing pharmaceutical knowledge for better health outcomes.
Publisher: OXFORD UNIV PRESSISSN: 1759-8885Frequency: 4 issues/year

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.